In COVID-19, increased levels of IL-6 support the differentiation of pro-inflammatory Th17 cells and a decrease of the T cells, such as CD4+ T cells, CD8+ T cells and natural killer (NK) cells [113]. This evidence concerns the gene IL6 and COVID-19.